{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:25:01Z","timestamp":1746303901935},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/rhu.0b013e31821c020a","type":"journal-article","created":{"date-parts":[[2012,12,17]],"date-time":"2012-12-17T17:57:41Z","timestamp":1355767061000},"page":"179-184","source":"Crossref","is-referenced-by-count":5,"title":["Outcome and Predictors of Kidney Disease Progression in Puerto Ricans With Systemic Lupus Erythematosus Initially Presenting With Mild Renal Involvement"],"prefix":"10.1097","volume":"17","author":[{"given":"Mariely","family":"Nieves-Plaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana P.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maril\u00fa","family":"Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda J.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesliane E.","family":"Castro-Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa E.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel M.","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis M.","family":"Vil\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-4-20210207","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1191\/0961203305lu2238oa","article-title":"Factors associated with poor outcomes in patients with lupus nephritis.","volume":"14","author":"Contreras","year":"2005","journal-title":"Lupus"},{"key":"R3-4-20210207","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0961203306074469","article-title":"Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.","volume":"16","author":"Mak","year":"2007","journal-title":"Lupus"},{"key":"R4-4-20210207","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1191\/0961203305lu2055oa","article-title":"Clinical presentation and monitoring of lupus nephritis.","volume":"14","author":"Balow","year":"2005","journal-title":"Lupus"},{"key":"R5-4-20210207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1191\/0961203305lu2059oa","article-title":"Lupus nephritis flares.","volume":"14","author":"Sidiropoulus","year":"2005","journal-title":"Lupus"},{"key":"R6-4-20210207","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1371\/journal.pmed.0030396","article-title":"Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort.","volume":"3","author":"Alarcon","year":"2006","journal-title":"PLoS Med"},{"key":"R7-4-20210207","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1191\/0961203302lu158oa","article-title":"Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis.","volume":"11","author":"Bastian","year":"2002","journal-title":"Lupus"},{"key":"R8-4-20210207","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.md.0000170022.44998.d1","article-title":"Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups.","volume":"84","author":"Mok","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"R9-4-20210207","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney Disease Outcome Quality Initiative.","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R10-4-20210207","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1046\/j.1523-1755.2002.00299.x","article-title":"Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency.","volume":"61","author":"Hsu","year":"2002","journal-title":"Kidney Int"},{"key":"R11-4-20210207","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/01.ASN.0000019646.05890.EA","article-title":"Perception versus reality of the burden of chronic kidney disease in the United States editorial.","volume":"13","author":"Coladonato","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R12-4-20210207","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R13-4-20210207","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus.","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R14-4-20210207","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R16-4-20210207","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/anr.1780320909","article-title":"Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.","volume":"32","author":"Liang","year":"1989","journal-title":"Arthritis Rheum"},{"key":"R17-4-20210207","first-page":"309","article-title":"Association of the Systemic Lupus Erythematosus International Collaborating Clinics\/American College of Rheumatology Damage Index with systemic lupus erythematosus.","volume":"24","author":"Stoll","year":"1997","journal-title":"J Rheumatol"},{"key":"R18-4-20210207","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus.","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"R19-4-20210207","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1191\/096120399678847605","article-title":"Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus.","volume":"8","author":"Mok","year":"1999","journal-title":"Lupus"},{"key":"R20-4-20210207","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/qjmed\/92.4.211","article-title":"The very long-term prognosis and complications of lupus nephritis and its treatment.","volume":"92","author":"Bono","year":"1999","journal-title":"QJM"},{"key":"R21-4-20210207","first-page":"251","article-title":"Predictors of end stage renal disease in African Americans with lupus nephritis.","volume":"68","author":"Franco","year":"2010","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"R22-4-20210207","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare.","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"key":"R23-4-20210207","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000075689","article-title":"The intricate role of complement component C4 in human systemic lupus erythematosus.","volume":"7","author":"Yang","year":"2004","journal-title":"Curr Dir Autoimmun"},{"key":"R24-4-20210207","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.4049\/jimmunol.173.4.2803","article-title":"Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus.","volume":"173","author":"Yang","year":"2004","journal-title":"J Immunol"},{"key":"R25-4-20210207","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2249.2009.03896.x","article-title":"Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.","volume":"156","author":"Gullstrand","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"R26-4-20210207","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1046\/j.1523-1755.2000.00045.x","article-title":"Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria.","volume":"57","author":"Hebert","year":"2000","journal-title":"Kidney Int"},{"key":"R27-4-20210207","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.ki.5000212","article-title":"The relationship between albuminuria, MCP-1\/CCL2, and interstitial macrophages in chronic kidney disease.","volume":"69","author":"Eardley","year":"2006","journal-title":"Kidney Int"},{"key":"R28-4-20210207","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.ASN.0000042167.66685.EA","article-title":"Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma.","volume":"14","author":"Arici","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R29-4-20210207","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.61.12.1065","article-title":"Definition of risk factors for death, end-stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.","volume":"61","author":"Manger","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R30-4-20210207","first-page":"332","article-title":"Renal biopsy in lupus patients with low levels of proteinuria.","volume":"34","author":"Christopher-Stine","year":"2007","journal-title":"J Rheumatol"},{"key":"R31-4-20210207","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3899\/jrheum.091028","article-title":"Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.","volume":"37","author":"Yip","year":"2010","journal-title":"J Rheumatol"},{"key":"R32-4-20210207","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1191\/0961203303lu259oa","article-title":"Silent lupus nephritis in systemic lupus erythematosus.","volume":"12","author":"Zabaleta-Lanz","year":"2003","journal-title":"Lupus"},{"key":"R33-4-20210207","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/0961203306070002","article-title":"Further description of early clinically silent lupus nephritis.","volume":"15","author":"Zabaleta","year":"2006","journal-title":"Lupus"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RHU.0b013e31821c020a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:55:49Z","timestamp":1620971749000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-201106000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e31821c020a","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}